{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:11:23Z","timestamp":1760145083648,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Malaria continues to be a significant global health challenge. The efficacy of artemisinin-based combination therapies (ACTs) has declined in many parts of the Greater Mekong Subregion, including Vietnam, due to the spread of resistant malaria strains. This study was conducted to assess the efficacy of the Dihydroartemisinin (DHA)\u2013Piperaquine (PPQ) regimen in treating uncomplicated falciparum malaria and to conduct molecular surveillance of antimalarial drug resistance in Binh Phuoc and Dak Nong provinces. Materials and Methods: The study included 63 uncomplicated malaria falciparum patients from therapeutic efficacy studies (TES) treated following the WHO treatment guidelines (2009). Molecular marker analysis was performed on all 63 patients. Methods encompassed Sanger sequencing for pfK13 mutations and quantitative real-time PCR for the pfpm2 gene. Results: This study found a marked decrease in the efficacy of the DHA-PPQ regimen, with an increased rate of treatment failures at two study sites. Genetic analysis revealed a significant presence of pfK13 mutations and pfpm2 amplifications, indicating emerging resistance to artemisinin and its partner drug. Conclusions: The effectiveness of the standard DHA-PPQ regimen has sharply declined, with rising treatment failure rates. This decline necessitates a review and possible revision of national malaria treatment guidelines. Importantly, molecular monitoring and clinical efficacy assessments together provide a robust framework for understanding and addressing detection drug resistance in malaria.<\/jats:p>","DOI":"10.3390\/medicina60061013","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:42:03Z","timestamp":1718883723000},"page":"1013","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Dihydroartemisinin\u2013Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam"],"prefix":"10.3390","volume":"60","author":[{"given":"Thu","family":"Tran","sequence":"first","affiliation":[{"name":"Institute of Biomedicine and Pharmacy, Vietnam Military Medical University, Hanoi 100000, Vietnam"},{"name":"Department of Biotechnology, Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bui","family":"Hien","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine and Pharmacy, Vietnam Military Medical University, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen","family":"Dung","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine and Pharmacy, Vietnam Military Medical University, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen","family":"Huong","sequence":"additional","affiliation":[{"name":"National Burn Hospital, Vietnam Military Medical University, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran","family":"Binh","sequence":"additional","affiliation":[{"name":"103 Hospital, Vietnam Military Medical University, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen","family":"Van Long","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine and Pharmacy, Vietnam Military Medical University, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0182-8996","authenticated-orcid":false,"given":"Nguyen","family":"Ton","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Graduate University of Science and Technology, Vietnam Academy of Science and Technology, Hanoi 100000, Vietnam"},{"name":"Institute of Genome Research, Vietnam Academy of Science and Technology, Hanoi 100000, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.2147\/IDR.S405668","article-title":"Malaria: An Overview","volume":"16","author":"Fikadu","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_2","unstructured":"World Heath Organization (2023). The World Malaria Report 2023."},{"key":"ref_3","unstructured":"WHO (2018). Strategy for Malaria Elimination in the Greater Melong Subregion (2015\u20132030)."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","article-title":"Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1","volume":"8","author":"Li","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lei, Z.N., Wu, Z.X., Dong, S., Yang, D.H., Zhang, L., Ke, Z., Zou, C., and Chen, Z.S. (2020). Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. Pharmacol. Ther., 216.","DOI":"10.1016\/j.pharmthera.2020.107672"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Shafik, S.H., Cobbold, S.A., Barkat, K., Richards, S.N., Lancaster, N.S., Llin\u00e1s, M., Hogg, S.J., Summers, R.L., McConville, M.J., and Martin, R.E. (2020). The natural function of the malaria parasite\u2019s chloroquine resistance transporter. Nat. Commun., 11.","DOI":"10.1038\/s41467-020-17781-6"},{"key":"ref_8","unstructured":"WHO (2023). WHO Guidelines for Malaria Treatment."},{"key":"ref_9","unstructured":"WHO (2019). Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010\u20132019)."},{"key":"ref_10","unstructured":"Ministry of Health Vietnam (2007). National Guideline of Malaria Diagnosis and Treatment."},{"key":"ref_11","unstructured":"Ministry of Health Vietnam (2007). Guidelines for Malaria Diagnosis and Treatment in Vietnam, Ministry of Health Vietnam, National Malaria Control Program."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bridgford, J.L., Xie, S.C., Cobbold, S.A., Pasaje, C.F.A., Herrmann, S., Yang, T., Gillett, D.L., Dick, L.R., Ralph, S.A., and Dogovski, C. (2018). Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat. Commun., 9.","DOI":"10.1038\/s41467-018-06221-1"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ma, N., Zhang, Z., Liao, F., Jiang, T., and Tu, Y. (2020). The birth of artemisinin. Pharmacol. Ther., 216.","DOI":"10.1016\/j.pharmthera.2020.107658"},{"key":"ref_14","unstructured":"WHO (2018). Artemisinin Resistance and Artemisinin-Based Combination Therapy Efficacy 2018."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Azmi, W.A., Rizki, A.F.M., Djuardi, Y., Artika, I.M., and Siregar, J.E. (2023). Molecular insights into artemisinin resistance in Plasmodium falciparum: An updated review. Infect. Genet. Evol., 112.","DOI":"10.1016\/j.meegid.2023.105460"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpddr.2019.10.001","article-title":"Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance","volume":"11","author":"Sharma","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13071-022-05239-1","article-title":"Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China\u2013Myanmar, Thailand\u2013Myanmar, and Thailand\u2013Cambodia borders","volume":"15","author":"Ye","year":"2022","journal-title":"Parasites Vectors"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10675","DOI":"10.1038\/s41598-019-47034-6","article-title":"Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13","volume":"9","author":"Jeffares","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pt.2020.03.006","article-title":"K13, the Cytostome, and Artemisinin Resistance","volume":"36","author":"Xie","year":"2020","journal-title":"Trends Parasitol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13071-023-06024-4","article-title":"What exactly does the PfK13 C580Y mutation in Plasmodium falciparum influence?","volume":"16","author":"Si","year":"2023","journal-title":"Parasites Vectors"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Stokes, B.H., Dhingra, S.K., Rubiano, K., Mok, S., Straimer, J., Gn\u00e4dig, N.F., Deni, I., Schindler, K.A., Bath, J.R., and Ward, K.E. (2021). Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness. Elife, 10.","DOI":"10.7554\/eLife.66277"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1038\/s41598-021-92735-6","article-title":"Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand","volume":"11","author":"Boonyalai","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12936-020-03249-x","article-title":"Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2\/3 copy number variation in Plasmodium falciparum","volume":"19","author":"Ansbro","year":"2020","journal-title":"Malar. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"14218","DOI":"10.1074\/jbc.274.20.14218","article-title":"Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton","volume":"274","author":"Deregnaucourt","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: A phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(23)00502-9","article-title":"Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: A descriptive epidemiological study","volume":"24","author":"Florimond","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12936-019-2756-4","article-title":"African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker","volume":"18","author":"Leroy","year":"2019","journal-title":"Malar. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Qidwai, T. (2020). Exploration of copy number variation in genes related to anti-malarial drug resistance in Plasmodium falciparum. Gene, 736.","DOI":"10.1016\/j.gene.2020.144414"},{"key":"ref_30","unstructured":"NIMPE (2023). Report of National Institute of Malariology Parasitology and Entomology, NIMPE."},{"key":"ref_31","unstructured":"WHO (2018). National Malaria Programme Review\u2013Viet Nam 2018."},{"key":"ref_32","unstructured":"National Institute of Malariology Parasitology and Entomology (2020). Report of National Institute of Malariology Parasitology and Entomology, 2020, National Institute of Malariology Parasitology and Entomology."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Quang, H.H., and Chavchich, M. (2021). Multidrug-Resistant Plasmodium falciparum Parasites in the Central Highlands of Vietnam Jeopardize Malaria Control and Elimination Strategies. Antimicrob. Agents Chemother., 65.","DOI":"10.1128\/AAC.01639-20"},{"key":"ref_34","unstructured":"World Health Organization (2015). Guidelines for the Treatment of Malaria."},{"key":"ref_35","unstructured":"WHO (2009). Methods for Surveillance of Antimalarial Drug Efficacy."},{"key":"ref_36","unstructured":"World Health Organization (2007, January 29\u201331). Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: Genotyping to Identify Parasite Populations. Proceedings of the Informal Consultation Organized by the Medicines for Malaria Venture and Cosponsored by the World Health Organization, Amsterdam, The Netherlands."},{"key":"ref_37","first-page":"103","article-title":"Genotyping of Plasmodium spp. Nested PCR","volume":"72","author":"Snounou","year":"2002","journal-title":"Methods Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3201\/eid2408.180370","article-title":"Plasmodium falciparum Plasmepsin 2 Duplications, West Africa","volume":"24","author":"Inoue","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_40","first-page":"71","article-title":"An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis","volume":"3","author":"Rao","year":"2013","journal-title":"Biostat. Bioinform. Biomath."},{"key":"ref_41","unstructured":"NIMPE (2013). Report of National Institute of Malariology Parasitology and Entomology, 2013, National Institute of Malariology Parasitology and Entomology."},{"key":"ref_42","unstructured":"National Institute of Malariology Parasitology and Entomology (2015). Report of National Institute of Malariology Parasitology and Entomology, 2015, National Institute of Malariology Parasitology and Entomology."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3201\/eid2304.161872","article-title":"Treatment Failure of Dihydroartemisinin\/Piperaquine for Plasmodium falciparum Malaria, Vietnam","volume":"23","author":"Phuc","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12936-017-1680-8","article-title":"Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam","volume":"16","author":"Thanh","year":"2017","journal-title":"Malar. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12936-022-04279-3","article-title":"Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009\u20132011: A randomized controlled trial and brief review","volume":"21","author":"Lek","year":"2022","journal-title":"Malar. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: A prospective clinical, pharmacological, and genetic study","volume":"19","author":"Imwong","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","article-title":"Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: An observational study","volume":"20","author":"Imwong","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Nair, S., Li, X., Arya, G.A., McDew-White, M., Ferrari, M., Nosten, F., and Anderson, T.J.C. (2018). Fitness Costs and the Rapid Spread of kelch13-C580Y Substitutions Conferring Artemisinin Resistance. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.00605-18"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kobasa, T., Talundzic, E., Sug-Aram, R., Boondat, P., Goldman, I.F., Lucchi, N.W., Dharmarak, P., Sintasath, D., Fukuda, M., and Whistler, T. (2018). Emergence and Spread of kelch13 Mutations Associated with Artemisinin Resistance in Plasmodium falciparum Parasites in 12 Thai Provinces from 2007 to 2016. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.02141-17"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: A genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1473-3099(17)30524-8","article-title":"Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/gbe\/evx126","article-title":"Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia","volume":"9","author":"Parobek","year":"2017","journal-title":"Genome Biol. Evol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/1013\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:01:46Z","timestamp":1760108506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/6\/1013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["medicina60061013"],"URL":"https:\/\/doi.org\/10.3390\/medicina60061013","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2024,6,20]]}}}